BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 19, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Feb. 11, 2020

View Archived Issues
2-11-Varian-Ethos.png

Varian receives FDA nod for Ethos therapy

Palo Alto, Calif.-based Varian Medical Systems Inc. has won the U.S. FDA’s nod for its Ethos therapy, an artificial intelligence (AI)-driven holistic solution that is aiming to transform cancer care. This solution is designed to deliver an entire adaptive treatment in a typical 15-minute slot and is intended to put the patient at the center of care, noted Chris Toth, president of Varian Oncology Systems. Read More

MITA urges FDA to make numerous technical changes to performance draft for MRI coils

The Dec. 9, 2019, FDA draft guidance spelling out performance criteria for magnetic resonance coils seemed to take up a relatively simple matter, but industry’s response suggested otherwise. The Medical Imaging & Technology Alliance (MITA) recommended that the agency undertake nearly two dozen changes to the draft, including a change to the title to indicate that the scope of the guidance is limited to receive-only MRI coils. Read More
2019-nCoV-CDC-pic2.png

WHO drawing research roadmap to combat coronavirus, newly named COVID-19

LONDON – As the death toll passed 1,000 and the number of confirmed cases reached 42,000, the World Health Organization on Feb. 11 convened 400 scientists at a global research and innovation forum to draw up an R&D blueprint for “pathogen X,” now officially named COVID-19. Read More
AI hands computer

Keeping pace with the digital revolution while searching for value

ANAHEIM, Calif. – The digital health wave is impacting seemingly every aspect of health care, from digital therapeutics where software is the therapy to powerful analytics that bring actionable insights to aid in a clinical situation. Read More
surgical-face-mask-coronavirus.png

Coronavirus-related panic purchases trigger supply chain disruptions

HONG KONG – The recent coronavirus (2019-nCov) scare has led to a rush of demand for masks that could soon strain pharmaceuticals and med-tech companies alike. In Hong Kong, queues for surgical masks now snake around the block. Read More
Pan-Cancer-project-2-5

Pan-Cancer Project looks closer, sees more

LONDON – The genomes of 38 different tumor types and the 47 million mutations that fostered their growth are revealed in unprecedented detail in 23 studies published in Nature and other journals on Feb. 6, 2020. Read More

Appointments and advancements for Feb. 11, 2020

New hires and promotions in the med-tech industry, including: Brainsway, Corwave, Genmark Diagnostics, Maravai Lifesciences, Nexstim, Noble, Sonion, Titan Medical. Read More

Financings for Feb. 11, 2020

Med-tech firms raising money in public or private financings, including: Co-Diagnostics, Genomic Vision, Myomo, Rewalk Robotics, Speedx, Stilla Technologies, Transenterix. Read More

In the clinic for Feb. 11, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Clinical Trials Mobile Application. Read More

Other news to note for Feb. 11, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Alr Technologies, Becton Dickinson, Biodesix, Caredx, Catalent, Clarity Pharmaceuticals, Companion Medical, Elypta, Eurofins, Icad, Intuitive Surgical, Limacorporate, Masthercell, Merck, Metactive Medical, Mogene, Natera, Neovasc, Northstar Medical Technologies, Olaris, Oncobeta, Orpheus Medical, P4 Diagnostix, Pfizer, Radiomedix, Resonetics, Royal Philips, Senseonics, Soliton, Strand Diagnostics, Techmah Medical, Tissium, Viracor. Read More

Regulatory actions for Feb. 11, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bluegrass Vascular, Enzo Clinical Labs, Implant Direct, Lucid Diagnostics, Medicrea, Varian. Read More

Regulatory front for Feb. 11, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies. Read More

BioWorld MedTech’s Oncology Extra for Feb. 11, 2020

Keeping you up to date on recent developments in oncology, including: Study bolsters case for maximal resection for glioblastoma; CD47 knockout improves antitumor vaccine; Distinguishing real from backseat drivers; Protons come to American state of Alabama. Read More

Popular Stories

  • Today's news in brief

    BioWorld

    BioWorld briefs for March 19, 2026.

  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing